MicroSurgical Technology
Greg Lincicome is an experienced Senior Manufacturing Engineer at MicroSurgical Technology, where the focus is on supporting the production of surgical equipment for eye surgery. Prior to this role, Greg served as NPI Leader at Cytiva, contributing to the launch of the OMX Flex super-resolution fluorescence microscope. Greg's career includes a long tenure at GE Healthcare as Staff Manufacturing Engineer, where responsibilities involved scaling production for advanced technologies. Earlier experience includes roles as Manufacturing Engineer at Boston Scientific and Heart Technology. Greg holds both a B.S. and M.S. in Mechanical Engineering from Stanford University, and completed secondary education at Bellevue Christian High School.
MicroSurgical Technology
MST’s passion is creating exceptional products that improve vision for patients all over the world. We strive to equip surgeons with the most innovative tools available, enabling them to achieve the best possible outcomes for their patients. We constantly evolve to meet the distinct clinical needs of ophthalmic surgeons through our dedicated partnership with surgeon-designers, bringing innovation to ophthalmology. Every MST product meets the highest standards and is designed to instill confidence during surgery. The MST team invests extraordinary care and attention into all elements of our products—not only in function but also in packaging, look and feel, and ease of adoption into the practice. MST is a highly profitable and fast-growing company headquartered in Redmond, Washington. MST is one of over fifty operating companies that form Halma PLC, a UK-based conglomerate with over $1.5B in annual sales and $4.5B in market value. Halma is listed on the London Stock Exchange and is a member of the FTSE 100 index. Halma’s business philosophy is to maintain the operating companies’ autonomy and entrepreneurship while providing the financial, operational and employee development resources that a world-class multi-national has to offer.